Masonic Cancer Center Director Search

Updated Sept. 5, 2024

There are two finalists for the Masonic Cancer Center Director position. Each candidate presented on the topic of "A Vision for the Future of MCC: Navigating the Challenges and Taking Advantage of Key Opportunities." Recordings of each presentation are available below.

Candidates

David Largaespada, PhD, professor in the Departments of Pediatrics and Genetics, Cell Biology, and Development, and the Associate Director for Basic Research in the Masonic Cancer Center

Presentation

Melissa Geller, MD, professor in the Department of Obstetrics, Gynecology and Women's Health, and associate director of Clinical Research in the Masonic Cancer Center

Presentation

Search Committee

Stephanie Terezakis, Department Head, Radiation Oncology, Medical School - Search Chair
Susan Arnold, Assistant Professor, Neurology and Neurosurgery, Veterinary Clinical Sciences
Kristin Artinger, Associate Dean for Research and Discovery, School of Dentistry
Anne Blaes, Director and Chair, Division of Hematology, Oncology and Transplantation
Rahel Ghebre, Professor, Department of Obstetrics, Division of Gynecologic Oncology
Daniel Harki, Northrop Professor and Director of Graduate Studies, Department of Medicinal Chemistry
Samir Khariwala, Department Chair, Otolaryngology
Tucker LeBien, Professor Emeritus, former Deputy Director of the Masonic Cancer Center
David Masopust, McKnight University Professor, HHMI Faculty Scholar, Center for Immunology
Nancy Sherwood, Associate Dean for Research, School of Public Health
Diane Treat-Jacobson, Associate Dean for Research, School of Nursing

The committee is responsible for identifying the challenges and opportunities of the search, providing input to the position profile, actively sourcing and screening potential candidates, and recommending finalists to the Vice President for Clinical Affairs.

The Office of Academic Clinical Affairs is conducting a search for the next Director of the Masonic Cancer Center (read job description).

The Masonic Cancer Center has been recognized as a National Cancer Institute designated comprehensive cancer center since 1998, indicating its preeminent scientific leadership, resources, and the depth and breadth of its research in basic, clinical, population, and translational sciences. As a comprehensive cancer center, the Masonic Cancer Center is characterized by scientific excellence and the capability to integrate a diversity of research approaches to focus on the problem of cancer.